INFLARX N.V. (IFRX) Business News March 13, 2026, 21:00 UTC InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement Full text
Register to leave comments News bot March 14, 2026, 11:06 a.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical